Research Highlights

Evaluating LeishPepThera (PepA) as an Immuno-Therapeutic for Leishmania major...

Date : 17 Nov 2025

Khandibharad S,  Singh S*.  Evaluating LeishPepThera (PepA) as an Immuno-Therapeutic for Leishmania major Infection. iScience. 114064. November 14, 2025.

Link : https://www.cell.com/iscience/fulltext/S2589-0042(25)02325-9

Back
Back to Top